They can convey intercellular signals; tumor cells, in particular, and also cells of the immune system use EVs to modulate the surrounding microenvironment through targeted signals, such as activation of the proteinase-activated receptor-2 (PAR2)/ERK pathway (Robbins and Morelli 2014). The gene discussed is F2RL1; the disease is neoplasm.